Cardiac involvement in Wilson disease: pathophysiology, clinical spectrum, and multimodality imaging assessment
Frontiers in Cardiovascular Medicine · 14.08.2026 · 13
DOI: 10.3389/fcvm.2026.1884519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 14.08.2026. Verfasst von Daiping Hua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac involvement in Wilson disease (WD), a rare autosomal recessive disorder of copper metabolism, has been historically underrecognized but is increasingly shown to be clinically significant. This review synthesizes the current understanding of the pathophysiology, clinical presentations, and the important but still evolving role of multimodality imaging in assessing cardiac disease in WD. Myocardial copper deposition directly and via secondary oxidative stress leads to cardiomyocyte injury, fibrosis, and electrical instability. The clinical spectrum ranges from subclinical abnormalities to overt cardiomyopathy, life-threatening arrhythmias, and sudden cardiac death. Electrocardiography often reveals conduction abnormalities and repolarization changes. Echocardiography, including advanced techniques like speckle-tracking, can detect subtle systolic and diastolic dysfunction, often before a decline in ejection fraction. Cardiovascular magnetic resonance (CMR) offers unique advantages for non-invasive tissue characterization and has shown promise in detecting myocardial abnormalities in WD, with studies consistently demonstrating increased extracellular volume, native T1/T2 values, and late gadolinium enhancement—particularly at the right ventricular insertion points and interventricular septum—indicating diffuse fibrosis and inflammation; however, its role in routine clinical practice remains to be standardized. Recent CMR studies also suggest concomitant coronary microvascular dysfunction. This review underscores the importance of systematic cardiac evaluation in WD patients, integrating clinical assessment with multimodality imaging to enable early detection, risk stratification, and timely intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
- Center of Imaging, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, China.
Zitieren
APA
Hua, D., Sun, L., Xiang, S., Yuan, Y., Xu, C., Xuan, Q., Yang, W., & Wang, H. (2026). Cardiac involvement in Wilson disease: pathophysiology, clinical spectrum, and multimodality imaging assessment. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1884519
Vancouver
Hua D, Sun L, Xiang S, Yuan Y, Xu C, Xuan Q, et al. Cardiac involvement in Wilson disease: pathophysiology, clinical spectrum, and multimodality imaging assessment. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1884519
BibTeX
@article{Hua2026,
author = {Hua, Daiping and Sun, Lanting and Xiang, Shang and Yuan, Ye and Xu, Chunsheng and Xuan, Qiaoyu and Yang, Wenming and Wang, Han},
title = {Cardiac involvement in Wilson disease: pathophysiology, clinical spectrum, and multimodality imaging assessment},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1884519}
}
EUVIMED